Selenium compounds and apoptotic modulation: a new perspective in cancer therapy

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Epidemiological studies suggest selenium's chemopreventive and anticancer properties against various human cancers.
• Proposed mechanisms include antiandrogen activity, growth inhibition via p53 regulation, and DNA damage.
• Apoptosis is a key mechanism underlying selenium's antitumorigenic effects.

Purpose of the Study:

• To review current knowledge on selenium's role in cancer therapy.
• To summarize the effects of over 28 selenium-containing molecules.
• To discuss the implications of selenium compounds in inducing apoptosis for cancer treatment.

Main Methods:

• Literature review of epidemiological studies and molecular mechanisms.
• Analysis of research on selenium compounds and their impact on cancer cells.
• Focus on apoptosis-regulating pathways involved with selenium.

Main Results:

• Selenium exhibits broad-spectrum anticancer activity.
• Apoptosis, mediated by mitochondrial pathways, caspases, and reactive oxygen species, is a primary anticancer mechanism.
• Numerous selenium compounds demonstrate potential in cancer therapy.

Conclusions:

• Selenium compounds are promising agents for cancer chemoprevention and therapy.
• Understanding selenium's role in apoptosis is crucial for developing novel cancer treatments.
• Further research into specific selenium molecules can optimize therapeutic strategies.